[HTML] nature.comFull View

[HTML][HTML] The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

V Rausch, N Giese, T Giese, F Schönsiegel… - Cell death & …, 2013 - nature.com
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer
stem cells (CSCs), which are not targeted by current therapies, may be the reason for …
被引用次数：136 相关文章

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, N Giese, T Giese, F Schönsiegel… - 2013 - katalog.ub.uni-heidelberg.de
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer
stem cells (CSCs), which are not targeted by current therapies, may be the reason for …

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, V Rausch, N Giese, T Giese… - Cell Death and …, 2013 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer
stem cells (CSCs), which are not targeted by current therapies, may be the reason for …
[HTML] nih.gov

[HTML][HTML] The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, V Rausch, N Giese, T Giese… - Cell Death & …, 2013 - ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer
stem cells (CSCs), which are not targeted by current therapies, may be the reason for …
[PDF] researchgate.net

[PDF][PDF] The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, V Rausch, N Giese, T Giese… - Cell Death and …, 2013 - researchgate.net
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell
signaling in pancreatic cancer Page 1 OPEN The novel c-Met inhibitor cabozantinib …

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer.

C Hage, V Rausch, N Giese, T Giese… - Cell Death & …, 2013 - europepmc.org
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer
stem cells (CSCs), which are not targeted by current therapies, may be the reason for …
[PDF] scienceopen.com

[PDF][PDF] The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, V Rausch, N Giese, T Giese… - Cell Death and …, 2013 - scienceopen.com
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell
signaling in pancreatic cancer Page 1 OPEN The novel c-Met inhibitor cabozantinib …
[PDF] cyberleninka.org

[PDF][PDF] The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, V Rausch, N Giese, T Giese… - Cell Death and …, 2013 - cyberleninka.org
The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell
signaling in pancreatic cancer Page 1 OPEN The novel c-Met inhibitor cabozantinib …

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, V Rausch, N Giese, T Giese… - Cell death & …, 2013 - pubmed.ncbi.nlm.nih.gov
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer
stem cells (CSCs), which are not targeted by current therapies, may be the reason for …

The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer

C Hage, V Rausch, N Giese, T Giese… - Cell Death and …, 2013 - search.proquest.com
Pancreatic ductal adenocarcinoma (PDA) is one of the most lethal malignancies. Cancer
stem cells (CSCs), which are not targeted by current therapies, may be the reason for …